Skip to content
Peptigraph home

Is CJC-1295 Legal? FDA, Compounding and WADA Status

CJC-1295's FDA status, compounding rules and anti-doping status, with a dated timeline of every change we track.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGHRH analogUpdated
FDA status
Not approved
research chemical
PCAC vote
Not reviewed
not on the Jul 2026 PCAC agenda
WADA
Prohibited (S2.2.4)
In and out of competition
Not legal adviceStatus reflects public FDA and WADA records on the date shown. Rules differ by country and state.

Current status

Not FDA approved · research chemical

No. CJC-1295 is not FDA approved for any use.

CJC-1295: regulatory status by country
CountryStatusSource
United StatesNo approved product foundNo FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "cjc-1295" returned no matches on 2 Oct 2026.api.fda.govchecked 2 Oct 2026

Timeline

No FDA, advisory-committee or WADA action specific to CJC-1295 found in our records (checked 2 Oct 2026).
Every peptide on the FDA tracker

Compounding and research-use sellers

  • Category 2 is the FDA's list of bulk substances it flagged as raising significant safety concerns. Compounding pharmacies are not expected to compound from them while they are on it.
  • The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on which substances belong on the 503A bulks list that pharmacies may compound from. Its votes are advice; the FDA decides.
  • "Research use only" products are sold outside these rules and are not checked by the FDA for identity, purity or dose.

FDA compounding record: CJC-1295 appears in FDA's table of bulk drug substances previously in category 2 and withdrawn by the nominators. · fda.gov, checked 2 Oct 2026

Sport and drug testing

Prohibited by WADA (S2.2.4)

CJC-1295 is named as a GHRH analogue in S2.2.4 (growth hormone releasing factors), prohibited at all times.

Outside the US

Rules differ by country. What each regulator's own records show, with the date we checked:

CJC-1295: regulatory status by country
CountryStatusSource
United KingdomNo approved product foundNo approved product found in an emc (UK SmPC compendium) search for "cjc-1295" on 2 Oct 2026.medicines.org.ukchecked 2 Oct 2026
CanadaNo approved product foundNo product found in a Health Canada Drug Product Database search for ingredient "cjc-1295" on 2 Oct 2026.health-products.canada.cachecked 2 Oct 2026
AustraliaNo approved product foundNo approved product found in an ARTG search for "cjc-1295" on 2 Oct 2026.tga.gov.auchecked 2 Oct 2026
European UnionNo centrally authorised EU medicine foundEMA medicines list, searched 2 Oct 2026ema.europa.euchecked 2 Oct 2026

FDA names two adverse effects for CJC-1295

FDA’s safety-risk entry for CJC-1295 says it has identified serious adverse events associated with the drug, including increased heart rate and a systemic vasodilatory reaction, and calls the clinical data limited.[3]

The entry also cites immunogenicity risk and difficulty characterizing the peptide and its impurities.[3]

In a dose-ranging trial in healthy adults, no serious adverse reactions were reported.[8]

Sport and registers

WADA's list names CJC-1295 among growth hormone-releasing hormone analogues, alongside sermorelin and tesamorelin.[1]

The Health Canada database returns no active-ingredient records for CJC-1295.[5]

The July 2026 advisory committee agenda excerpt lists BPC-157, KPV, TB-500 and MOTS-c, not CJC-1295.[9]

Common questions

Is CJC-1295 FDA approved?

No. Drugs@FDA returns no match for CJC-1295.[2]

Is CJC-1295 legal to buy?

It is not an approved drug. Online sellers label it "for research use only, not for human use"; the FDA sent warning letters to five such sellers on 24 Aug 2026. Whether a pharmacy may compound it depends on its FDA bulk-substance status. Rules differ by country.

Is CJC-1295 banned by WADA?

Yes. Prohibited by WADA (S2.2.4), in and out of competition.

Is CJC-1295 legal?

FDA's 503A page says state-licensed physicians and pharmacists may only compound drug products using bulk drug substances that meet listed conditions.[10]

Is CJC-1295 banned?

In sport, WADA's list names CJC-1295 as a GHRH analogue.[1]

More on CJC-1295

Sources

  1. 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  2. 2United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "cjc-1295" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  3. 3US compounding: CJC-1295 appears in FDA's table of bulk drug substances previously in category 2 and withdrawn by the nominators.U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  4. 4United Kingdom: No approved product found in an emc (UK SmPC compendium) search for "cjc-1295" on 2 Oct 2026.Electronic Medicines Compendium (UK) · 2026medicines.org.ukAccessed 2 Oct 2026
  5. 5Canada: No product found in a Health Canada Drug Product Database search for ingredient "cjc-1295" on 2 Oct 2026.Health Canada · 2026health-products.canada.caAccessed 2 Oct 2026
  6. 6Australia: No approved product found in an ARTG search for "cjc-1295" on 2 Oct 2026.Therapeutic Goods Administration (Australia) · 2026tga.gov.auAccessed 2 Oct 2026
  7. 7EMA medicines export (centrally authorised medicines) (searched 2 Oct 2026)European Medicines Agency · 2026ema.europa.euAccessed 2 Oct 2026
  8. 8Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.The Journal of clinical endocrinology and metabolism · 2006PMID 16352683Accessed 2 Oct 2026
  9. 9Official web pageOfficial web page · web page
  10. 10Official web pageOfficial web page · web page

Found an error? Report a correction.